During the last session, Kestra Medical Technologies Ltd (NASDAQ:KMTS)’s traded shares were 0.31 million. At the end of the trading day, the stock’s price was $14.91, reflecting an intraday loss of -1.84% or -$0.28. The 52-week high for the KMTS share is $26.15, that puts it down -75.39 from that peak though still a striking 5.57% gain since the share price plummeted to a 52-week low of $14.08. The company’s market capitalization is $765.61M, and the average intraday trading volume over the past 10 days was 0.55 million shares, and the average trade volume was 245.77K shares over the past three months.
Kestra Medical Technologies Ltd (NASDAQ:KMTS) trade information
Kestra Medical Technologies Ltd (KMTS) registered a -1.84% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -1.84% in intraday trading to $14.91, hitting a weekly high. The stock’s 5-day price performance is -4.85%, and it has moved by -27.27% in 30 days. Based on these gigs, the overall price performance for the year is -31.73%. The short interest in Kestra Medical Technologies Ltd (NASDAQ:KMTS) is 1.14 million shares and it means that shorts have 9.2 day(s) to cover.
KMTS Dividends
Kestra Medical Technologies Ltd is due to release its next quarterly earnings in August. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Kestra Medical Technologies Ltd (NASDAQ:KMTS)’s Major holders
Kestra Medical Technologies Ltd insiders own 6.09% of total outstanding shares while institutional holders control 88.10%, with the float percentage being 93.81%.
Also, the Mutual Funds coming in first place with the largest holdings of Kestra Medical Technologies Ltd (KMTS) shares are Fidelity Select Portfolios-Medical Technology and Devices Portfolio and AB CAP FUND, INC.-AB Small Cap Growth Portfolio . Data provided on May 31, 2025 indicates that Fidelity Select Portfolios-Medical Technology and Devices Portfolio owns about 800.0 shares. This amounts to just over 1.56 percent of the company’s overall shares, with a $11.93 million market value. The same data shows that the other fund manager holds slightly less at 641.27, or about 1.25% of the stock, which is worth about $9.56 million.
